X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22752) 22752
Publication (1675) 1675
Book Review (508) 508
Book Chapter (111) 111
Magazine Article (96) 96
Book / eBook (31) 31
Dissertation (27) 27
Conference Proceeding (26) 26
Trade Publication Article (11) 11
Web Resource (9) 9
Data Set (6) 6
Government Document (3) 3
Presentation (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15516) 15516
animals (9493) 9493
anti-inflammatory agents, non-steroidal - pharmacology (8691) 8691
male (8214) 8214
index medicus (7976) 7976
anti-inflammatory agents, non-steroidal - therapeutic use (7843) 7843
female (6542) 6542
anti-inflammatory agents, non-steroidal - adverse effects (5249) 5249
pharmacology & pharmacy (4247) 4247
rats (3939) 3939
mice (3559) 3559
nonsteroidal antiinflammatory drugs (3299) 3299
middle aged (3269) 3269
anti-inflammatory agents, non-steroidal - administration & dosage (2943) 2943
adult (2897) 2897
aged (2778) 2778
inflammation (2456) 2456
dose-response relationship, drug (2133) 2133
risk factors (1984) 1984
nonsteroidal anti-inflammatory drugs (1817) 1817
anti-inflammatory agents, non-steroidal - chemistry (1704) 1704
aspirin (1685) 1685
biochemistry & molecular biology (1657) 1657
cyclooxygenase inhibitors - pharmacology (1622) 1622
cyclooxygenase inhibitors - therapeutic use (1613) 1613
rheumatoid-arthritis (1595) 1595
celecoxib (1591) 1591
cyclooxygenase 2 (1567) 1567
treatment outcome (1557) 1557
chemistry, medicinal (1502) 1502
expression (1447) 1447
medicine, general & internal (1374) 1374
cyclooxygenase inhibitors - adverse effects (1352) 1352
membrane proteins (1342) 1342
cyclooxygenase 2 inhibitors (1283) 1283
gastroenterology & hepatology (1271) 1271
risk (1232) 1232
rats, sprague-dawley (1227) 1227
cox-2 inhibitors (1184) 1184
immunology (1152) 1152
research (1148) 1148
rats, wistar (1119) 1119
inhibition (1115) 1115
cells, cultured (1114) 1114
disease models, animal (1113) 1113
double-blind (1110) 1110
analysis (1097) 1097
nsaids (1082) 1082
rheumatology (1079) 1079
oncology (1071) 1071
tumor necrosis factor-alpha - antagonists & inhibitors (1037) 1037
care and treatment (1032) 1032
apoptosis (1030) 1030
time factors (995) 995
indomethacin (987) 987
indomethacin - pharmacology (972) 972
drug therapy (971) 971
structure-activity relationship (960) 960
cyclooxygenase-2 (949) 949
drug therapy, combination (942) 942
osteoarthritis (940) 940
non-steroidal anti-inflammatory drugs (917) 917
cell line (914) 914
aged, 80 and over (913) 913
cancer (909) 909
inhibitors (906) 906
drugs (903) 903
prevention (893) 893
anti-inflammatory agents, non-steroidal - chemical synthesis (884) 884
enzyme inhibitors - pharmacology (877) 877
pain (873) 873
in-vitro (857) 857
aspirin - therapeutic use (853) 853
double-blind method (851) 851
drug interactions (832) 832
cells (826) 826
isoenzymes - antagonists & inhibitors (826) 826
activation (823) 823
inflammation - drug therapy (817) 817
prostaglandin-endoperoxide synthases - metabolism (811) 811
aspirin - adverse effects (808) 808
anti-inflammatory drugs (787) 787
aspirin - pharmacology (783) 783
nf-kappa-b (783) 783
molecular structure (781) 781
arthritis (760) 760
apoptosis - drug effects (757) 757
health aspects (757) 757
adolescent (742) 742
cell biology (739) 739
therapy (739) 739
in vitro techniques (738) 738
cyclooxygenase (737) 737
anti-inflammatory agents, non-steroidal - pharmacokinetics (713) 713
medicine & public health (697) 697
arthritis, rheumatoid - drug therapy (695) 695
disease (690) 690
pain - drug therapy (672) 672
administration, oral (670) 670
rofecoxib (664) 664
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21383) 21383
German (347) 347
French (282) 282
Japanese (206) 206
Spanish (163) 163
Russian (123) 123
Italian (68) 68
Chinese (61) 61
Polish (49) 49
Korean (36) 36
Norwegian (35) 35
Dutch (34) 34
Swedish (33) 33
Danish (32) 32
Hungarian (26) 26
Portuguese (20) 20
Croatian (18) 18
Czech (17) 17
Finnish (14) 14
Slovak (9) 9
Turkish (8) 8
Ukrainian (8) 8
Bulgarian (7) 7
Hebrew (7) 7
Romanian (5) 5
Serbian (4) 4
Bosnian (1) 1
Greek (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2004, Milestones in drug therapy., ISBN 3764369019, x, 249
Book
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2016, Volume 14, Issue 6, pp. 809 - 815.e1
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 06/2006, Volume 98, Issue 11, pp. 736 - 747
Journal Article
Pharmacoepidemiology and Drug Safety, ISSN 1053-8569, 10/2017, Volume 26, Issue 10, pp. 1141 - 1148
PurposeTo assess the risk of gastrointestinal perforation, ulcers, or bleeding (PUB) associated with the use of conventional nonsteroidal anti-inflammatory... 
proton pump inhibitors | bleeding | gastrointestinal toxicity | perforation | selective COX‐2 inhibitors | ulcers | conventional NSAIDs | selective COX-2 inhibitors | RHEUMATOID-ARTHRITIS | CARDIOVASCULAR EVENTS | NONSELECTIVE NSAIDS | CELECOXIB | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | CONTROLLED TRIALS | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | HIGH-RISK | CYCLOOXYGENASE-2 INHIBITORS | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | OSTEOARTHRITIS | Age Factors | Humans | Middle Aged | Peptic Ulcer - prevention & control | Male | Peptic Ulcer - epidemiology | Gastrointestinal Hemorrhage - epidemiology | Case-Control Studies | Cyclooxygenase 2 Inhibitors - adverse effects | Peptic Ulcer Perforation - epidemiology | Pain - drug therapy | Pain Management - adverse effects | Aged, 80 and over | Female | Odds Ratio | Peptic Ulcer - complications | Risk Factors | Pain Management - methods | Proton Pump Inhibitors - therapeutic use | Gastrointestinal Hemorrhage - chemically induced | Gastrointestinal Hemorrhage - prevention & control | Peptic Ulcer Perforation - prevention & control | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Aged | Peptic Ulcer - chemically induced | Peptic Ulcer Perforation - etiology | COX-2 inhibitors | Proton pump inhibitors | Nonsteroidal anti-inflammatory drugs | Drugs | Antiinflammatory agents | Control methods | Adjustment | Toxicity | Perforation | Pharmacology | Inflammation | Regression analysis | Patients | Risk factors | Bleeding | Confidence intervals | Inhibitors | Ulcers | Cyclooxygenase-2 | Health risk assessment | Index Medicus | Original Report | Original Reports
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 01/2013, Volume 108, Issue 1, pp. 99 - 105
OBJECTIVES: The risk of non-Hodgkin's lymphoma (NHL) with tumor necrosis factor alpha (TNF-alpha) inhibitors is unclear, whether related to concomitant... 
RHEUMATOID-ARTHRITIS | INFLAMMATORY-BOWEL-DISEASE | THERAPY | AZATHIOPRINE | RISK | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | CANCER | MEDLINE | Azathioprine - therapeutic use | Lymphoma, T-Cell - chemically induced | Certolizumab Pegol | United States | Humans | Immunoglobulin Fab Fragments - adverse effects | Immunosuppressive Agents - therapeutic use | Middle Aged | Antibodies, Monoclonal - adverse effects | Polyethylene Glycols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Immunoglobulin Fab Fragments - therapeutic use | Polyethylene Glycols - therapeutic use | Receptors, Tumor Necrosis Factor - therapeutic use | Etanercept | Infliximab | Arthritis, Rheumatoid - drug therapy | Mercaptopurine - therapeutic use | Aged, 80 and over | Adult | Female | Drug Therapy, Combination | Odds Ratio | United States Food and Drug Administration | Inflammatory Bowel Diseases - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | SEER Program | Antibodies, Monoclonal, Humanized - therapeutic use | Psoriasis - drug therapy | Adverse Drug Reaction Reporting Systems | Risk Factors | Spondylitis, Ankylosing - drug therapy | Mercaptopurine - adverse effects | Immunoglobulin G - therapeutic use | Immunoglobulin G - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Immunosuppressive Agents - adverse effects | Aged | Adalimumab | Azathioprine - adverse effects | Tumor Necrosis Factor-alpha - antagonists & inhibitors
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 11/2006, Volume 49, Issue 23, pp. 6819 - 6832
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 09/2017, Volume 139, pp. 40 - 55
Many chronic human diseases, including multiple neurodegenerative diseases, are associated with deleterious protein aggregates, also called protein amyloids.... 
Covalent mechanisms | Non-covalent mechanisms | Amyloid inhibitor | Natural products | Inhibition mechanisms | CLINICAL-TRIAL | PROTEIN AGGREGATION | ALZHEIMERS-DISEASE | SOLID DISPERSION | TEA POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE | ALPHA-SYNUCLEIN AGGREGATION | BETA-PEPTIDE AGGREGATION | A-BETA | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | AROMATIC-INHIBITOR | Amyloidosis - prevention & control | Drugs, Investigational - pharmacology | Antioxidants - chemistry | Nootropic Agents - metabolism | Antioxidants - metabolism | Healthy Diet | Humans | Polyphenols - pharmacology | Drugs, Investigational - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Biological Products - pharmacology | Flavonoids - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Polyphenols - metabolism | Amyloidogenic Proteins - antagonists & inhibitors | Drugs, Investigational - chemistry | Protein Aggregation, Pathological - prevention & control | Amyloidosis - diet therapy | Drug Design | Flavonoids - pharmacology | Protein Aggregation, Pathological - diet therapy | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Chelating Agents - therapeutic use | Biological Products - therapeutic use | Chelating Agents - chemistry | Nootropic Agents - therapeutic use | Amyloidosis - drug therapy | Antioxidants - pharmacology | Chelating Agents - pharmacology | Nootropic Agents - chemistry | Drug Discovery | Protein Aggregation, Pathological - drug therapy | Amyloidogenic Proteins - metabolism | Antioxidants - therapeutic use | Biological Products - chemistry | Animals | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Flavonoids - metabolism | Polyphenols - chemistry | Biological Products - metabolism | Polyphenols - therapeutic use | Chelating Agents - metabolism | Dietary Supplements | Flavonoids - chemistry | Amyloidosis - metabolism | Nootropic Agents - pharmacology | Medicine, Experimental | Medical research | Nervous system diseases | Glycoproteins | Drug discovery | Index Medicus
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 05/2016, Volume 114, pp. 170 - 190
Journal Article